Catalyst Wire Dossier Catalyst Wire Dossier

GLIADEL wafer

carmustine
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for GLIADEL wafer, covering 2009-09-18 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma [Phase 1]

See pricing